Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Acacia, Alligator, Anixa, Axim, Biotheus, Cellectar, Censa, Codiak, Cosmo, Diffusion, Emergent, G3, Hua, Intellia, Jacobio, Junshi, Juvenescence, Kalytera, Mateon, Merck, Mimivax, Motif, Ontochem, Oryzon, Proteostasis, PTC, Rakuten Medical, Regeneron, Resverlogix, Revance, Sanofi, Synlogic, Tonix, Fujifilm Diosynth, Twist Bioscience, Proteona, Spark, Vault.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aileron, Antibe, Belx, Biomarin, CTI, Gilead, GSK, Histogen, Iterum, Lineage Cell, Merck, Mesoblast, Moderna, Novartis, Novus, Ocugen, Pfizer, TLC.

Biopharmas raising money in public or private financings, including: Adaptimmune, Allogene, Baudax Bio, Biolinerx, Calliditas, Cleveland Biolabs, Nabriva.

New hires and promotions in the biopharma industry, including: Biond, Celyad, Iteos, Neoleukin, Oxford Biomedica, Samumed, Sanifit, Swanbio, Trisalus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baibies, Letsgetchecked.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Acupath, Aeec, Eurofins, Genestack, Google Cloud, Ioniq, Labware, Mission Bio, Nano Diagnosix, Orasure, Prolung, Rockland Immunochemicals, SI-Bone, Tangen, Thermo Fisher, Ursure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocept, Caris Life Sciences, Creatv Microtech, Foundation Medicine, Hesperos, Myriad, Personalis, Sengine Precision Medicine, Tiziana Life Sciences.

Med-tech firms raising money in public or private financings, including: Digirad, Genetic Technologies, Hamilton Thorne.

New hires and promotions in the med-tech industry, including: Iradimed, Orasure Technologies.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Boehringer, Chi-Med, Immune-Onc, J&J, Lilly, Menlo, Nabriva, Novartis, Onxeo, Orphazyme, Roche, Santhera, Takeda.